Search research articles
Contact Us
Filters
Showing results (301-310 of 348) with videos related to
Page
of 35
Sort By:
The New England Journal of Medicine
|
December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Pain
|
April 21, 2025
Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318
Lisa M Broad, Jeffrey G Suico, P Kellie Turner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Clinical and Translational Radiation Oncology
|
January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy
Nikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Clinical Transplantation
|
March 9, 2019
Gene signatures common to allograft rejection are associated with lymphocytic bronchitis
John R Greenland, Ping Wang, Joshua J Brotman, et al.
JAMA Dermatology
|
April 2, 2025
Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome
Omar Elghawy, Jonathan H Sussman, Austin G Yang, et al.
Neuro-Oncology Advances
|
May 2, 2023
Retrospective examination of pseudoprogression in <i>IDH</i> mutant gliomas
Ethan A Wetzel, Matthew J Farrell, Blaine S C Eldred, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Leukemia
|
February 17, 2026
Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma
Daniel J Landsburg, Nancy Musoke, Caren Gentile, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 348) with videos related to
Sort By:
Page
of 35
The New England Journal of Medicine
|
December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Pain
|
April 21, 2025
Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318
Lisa M Broad, Jeffrey G Suico, P Kellie Turner, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Clinical and Translational Radiation Oncology
|
January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy
Nikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Clinical Transplantation
|
March 9, 2019
Gene signatures common to allograft rejection are associated with lymphocytic bronchitis
John R Greenland, Ping Wang, Joshua J Brotman, et al.
JAMA Dermatology
|
April 2, 2025
Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome
Omar Elghawy, Jonathan H Sussman, Austin G Yang, et al.
Neuro-Oncology Advances
|
May 2, 2023
Retrospective examination of pseudoprogression in <i>IDH</i> mutant gliomas
Ethan A Wetzel, Matthew J Farrell, Blaine S C Eldred, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Leukemia
|
February 17, 2026
Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma
Daniel J Landsburg, Nancy Musoke, Caren Gentile, et al.
Page
of 35